Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Obesity

  Free Subscription


Articles published in Eur J Endocrinol

Retrieve available abstracts of 44 articles:
HTML format



Single Articles


    November 2021
  1. ZHANG J, Chen X, Liu W, Zhang C, et al
    Metabolic surgery improves the unbalanced proportion of peripheral blood myeloid dendritic cells and T lymphocytes in obese patients.
    Eur J Endocrinol. 2021;185:819-829.
    PubMed     Abstract available


  2. MANGOLIM AS, Brito LAR, Nunes-Nogueira VDS
    Effectiveness of testosterone replacement in men with obesity: a systematic review and meta-analysis.
    Eur J Endocrinol. 2021 Nov 1. pii: EJE-21-0473.R1. doi: 10.1530/EJE-21-0473.
    PubMed     Abstract available


  3. YANG R, Hu Y, Lee CH, Liu Y, et al
    PM20D1 Is a Circulating Biomarker Closely Associated with Obesity, Insulin resistance and Metabolic Syndrome.
    Eur J Endocrinol. 2021 Nov 1. pii: EJE-21-0847.R1. doi: 10.1530/EJE-21-0847.
    PubMed     Abstract available


    October 2021
  4. ROMERO-RUIZ A, Pineda B, Ovelleiro D, Perdices-Lopez C, et al
    Molecular diagnosis of polycystic ovary syndrome in obese and non-obese women by targeted plasma miRNA profiling.
    Eur J Endocrinol. 2021;185:637-652.
    PubMed     Abstract available


    September 2021
  5. ANDERSEN MR, Suppli MP, Bagger JI, Christensen MB, et al
    MECHANISMS IN ENDOCRINOLOGY: The physiology of neuronostatin.
    Eur J Endocrinol. 2021;185:R93-R101.
    PubMed     Abstract available


    August 2021
  6. NOGUEIRAS R
    MECHANISMS IN ENDOCRINOLOGY: The gut-brain axis: regulating energy balance independent of food intake.
    Eur J Endocrinol. 2021;185:R75-R91.
    PubMed     Abstract available


    June 2021
  7. LEITER A, Carroll E, De Alwis S, Brooks D, et al
    Metabolic disease and adverse events from immune checkpoint inhibitors.
    Eur J Endocrinol. 2021;184:857-865.
    PubMed     Abstract available


    May 2021
  8. GROOTJEN LN, Rutges JPHJ, Damen L, Donze SH, et al
    Effects of 8 years of growth hormone treatment on scoliosis in children with Prader-Willi syndrome.
    Eur J Endocrinol. 2021;185:47-55.
    PubMed     Abstract available


  9. DAMEN L, Grootjen LN, Donze SH, de Graaff LCG, et al
    Bone mineral density during 3 years of growth hormone in previously GH-treated young adults with PWS.
    Eur J Endocrinol. 2021;184:773-782.
    PubMed     Abstract available


  10. MCNEILL BT, Suchacki KJ, Stimson RH
    MECHANISMS IN ENDOCRINOLOGY: Human brown adipose tissue as a therapeutic target: warming up or cooling down?
    Eur J Endocrinol. 2021;184:R243-R259.
    PubMed     Abstract available


  11. SUBRAMANIAN A, Anand A, Adderley NJ, Okoth K, et al
    Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study.
    Eur J Endocrinol. 2021;184:637-645.
    PubMed     Abstract available


  12. DE ZEGHER F, Ibanez L
    On the rising incidence of early breast development: puberty as an adaptive escape from ectopic adiposity in mismatch girls.
    Eur J Endocrinol. 2021 May 1. pii: EJE-21-0287. doi: 10.1530/EJE-21-0287.
    PubMed     Abstract available


  13. LEGER J, Delcour C, De Roux N, Carel JC, et al
    Response to letter to the editor (from De Zegher and Ibanes) (On the rising incidence of early breast development: puberty as an adaptive escape from ectopic adiposity in mismatch girls).
    Eur J Endocrinol. 2021 May 1. pii: EJE-21-0445. doi: 10.1530/EJE-21-0445.
    PubMed     Abstract available


    April 2021
  14. REYES M, Gonzalez L, Ibeas K, Cereijo R, et al
    White adipose tissue-infiltrated CD11b+ myeloid cells are a source of S100A4, a new potential marker of hepatic damage.
    Eur J Endocrinol. 2021;184:533-541.
    PubMed     Abstract available


  15. JUN JE, Kang M, Jin SM, Kim K, et al
    Additive effect of low skeletal muscle mass and abdominal obesity on coronary artery calcification.
    Eur J Endocrinol. 2021 Apr 1. pii: EJE-20-0885.R1. doi: 10.1530/EJE-20-0885.
    PubMed     Abstract available


  16. STENSEN S, Gasbjerg LS, Krogh LL, Skov-Jeppesen K, et al
    Effects of endogenous GIP in patients with type 2 diabetes.
    Eur J Endocrinol. 2021 Apr 1. pii: EJE-21-0135.R1. doi: 10.1530/EJE-21-0135.
    PubMed     Abstract available


    January 2021
  17. VALDES N, Tirosh A, Keil M, Stratakis CA, et al
    Pediatric Cushing's syndrome: greater risk of being overweight or obese after long-term remission and its predictive factors.
    Eur J Endocrinol. 2021;184:179-187.
    PubMed     Abstract available


    December 2020
  18. LAPAUW B, Kaufman JM
    MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications.
    Eur J Endocrinol. 2020;183:R167-R183.
    PubMed     Abstract available


    November 2020
  19. BEAVERS KM, Greene KA, Yu EW
    MANAGEMENT OF ENDOCRINE DISEASE: Bone complications of bariatric surgery: updates on sleeve gastrectomy, fractures, and interventions.
    Eur J Endocrinol. 2020;183:R119-R132.
    PubMed     Abstract available


  20. POITOU C, Mosbah H, Clement K
    MECHANISMS IN ENDOCRINOLOGY: Update on treatments for patients with genetic obesity.
    Eur J Endocrinol. 2020;183:R149-R166.
    PubMed     Abstract available


    October 2020
  21. MARLATT KL, Lovre D, Beyl RA, Tate CR, et al
    Effect of conjugated estrogens and bazedoxifene on glucose, energy and lipid metabolism in obese postmenopausal women.
    Eur J Endocrinol. 2020;183:439-452.
    PubMed     Abstract available


    September 2020
  22. VAN DER VALK ES, van der Voorn B, Iyer AM, van den Berg S, et al
    In adults with obesity, copeptin is linked with BMI but is not associated with long-term exposure to cortisol and cortisone.
    Eur J Endocrinol. 2020 Sep 1. pii: EJE-20-0077.R1. doi: 10.1530/EJE-20-0077.
    PubMed     Abstract available


    August 2020
  23. SALERNO M, Improda N, Capalbo D
    MANAGEMENT OF ENDOCRINE DISEASE Subclinical hypothyroidism in children.
    Eur J Endocrinol. 2020;183:R13-R28.
    PubMed     Abstract available


    July 2020
  24. OBERG E, Lundell C, Blomberg L, Gidlof SB, et al
    Psychological well-being and personality in relation to weight loss following behavioral modification intervention in obese women with polycystic ovary syndrome: a randomized controlled trial.
    Eur J Endocrinol. 2020;183:1-11.
    PubMed     Abstract available


  25. FORTUIN-DE SMIDT MC, Mendham AE, Hauksson J, Hakim O, et al
    Effect of exercise training on insulin sensitivity, hyperinsulinemia and ectopic fat in black South African women: a randomized controlled trial.
    Eur J Endocrinol. 2020;183:51-61.
    PubMed     Abstract available


  26. CLARKE BM, Vincent AD, Martin S, Adams R, et al
    Obstructive sleep apnea is not an independent determinant of testosterone in men.
    Eur J Endocrinol. 2020;183:31-39.
    PubMed     Abstract available


  27. ROTTOLI M, Bernante P, Belvedere A, Balsamo F, et al
    How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre.
    Eur J Endocrinol. 2020 Jul 1. pii: EJE-20-0541.R2. doi: 10.1530/EJE-20-0541.
    PubMed     Abstract available


  28. RADETTI G, Fanolla A, Lupi F, Sartorio A, et al
    BMI as criterion to start the work up in obesity.
    Eur J Endocrinol. 2020 Jul 1. pii: EJE-20-0640.R1. doi: 10.1530/EJE-20-0640.
    PubMed     Abstract available


    June 2020
  29. DEAL CL, Rogol AD
    Growth hormone treatments and cognitive functioning in children with Prader-Willi syndrome.
    Eur J Endocrinol. 2020;182:C21-C25.
    PubMed    


    May 2020
  30. MEZZULLO M, Di Dalmazi G, Fazzini A, Baccini M, et al
    Impact of age, body weight and metabolic risk factors on steroid reference intervals in men.
    Eur J Endocrinol. 2020;182:459-471.
    PubMed     Abstract available


  31. SPRUNG VS, Bowden Davies KA, Norman JA, Thompson A, et al
    Metabolic syndrome is associated with reduced flow mediated dilation independent of obesity status.
    Eur J Endocrinol. 2020 May 1. pii: EJE-20-0098.R1. doi: 10.1530/EJE-20-0098.
    PubMed     Abstract available


    April 2020
  32. LI G, Li Y, Han L, Wang D, et al
    Interaction between early environment and genetic predisposition instigates the metabolically obese, normal weight phenotype in children: findings from the BCAMS study.
    Eur J Endocrinol. 2020;182:393-403.
    PubMed     Abstract available


  33. DONZE SH, Damen L, Mahabier EF, Hokken-Koelega ACS, et al
    Cognitive functioning in children with Prader-Willi syndrome during 8 years of growth hormone treatment.
    Eur J Endocrinol. 2020;182:405-411.
    PubMed     Abstract available


    March 2020
  34. HANSEN S, Jorgensen NR, Hermann AP, Stoving RK, et al
    Continuous decline in bone mineral density and deterioration of bone microarchitecture 7 years after Roux-en-Y gastric bypass surgery.
    Eur J Endocrinol. 2020;182:303-311.
    PubMed     Abstract available


    February 2020
  35. WILDING JP
    Endocrine testing in obesity.
    Eur J Endocrinol. 2020 Feb 1. pii: EJE-20-0099. doi: 10.1530/EJE-20-0099.
    PubMed     Abstract available


  36. SHEN Z, Cen L, Chen X, Pan J, et al
    Increased risk of low bone mineral density in patients with non-alcoholic fatty liver disease: a cohort study.
    Eur J Endocrinol. 2020;182:157-164.
    PubMed     Abstract available


    January 2020
  37. PASQUALI R, Casanueva F, Haluzik M, van Hulsteijn L, et al
    European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity.
    Eur J Endocrinol. 2020;182:G1-G32.
    PubMed     Abstract available


  38. BELLO O, Ladwa M, Hakim O, Marathe C, et al
    Differences in the link between insulin sensitivity and ectopic fat in men of Black African and White European ethnicity.
    Eur J Endocrinol. 2020;182:91-101.
    PubMed     Abstract available


  39. VAN HULSTEIJN LT, Pasquali R, Casanueva F, Haluzik M, et al
    Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis.
    Eur J Endocrinol. 2020;182:11-21.
    PubMed     Abstract available


    December 2019
  40. RICOTTI R, Solito A, Mariotti Zani E, Caputo M, et al
    THE RELATIONSHIP BETWEEN CORTISOL AND IGF-I INFLUENCES METABOLIC ALTERATION IN PEDIATRIC OVERWEIGHT AND OBESITY.
    Eur J Endocrinol. 2019 Dec 1. pii: EJE-19-0792.R1. doi: 10.1530/EJE-19-0792.
    PubMed     Abstract available


    November 2019
  41. FITTIPALDI A, Hernandez J, Castrogiovanni D, Lufrano D, et al
    PLASMA LEVELS OF GHRELIN, DES-ACYL GHRELIN AND LEAP2 IN CHILDREN WITH OBESITY: CORRELATION WITH AGE AND INSULIN RESISTANCE.
    Eur J Endocrinol. 2019 Nov 1. pii: EJE-19-0684.R2. doi: 10.1530/EJE-19-0684.
    PubMed     Abstract available


  42. RAZNY U, Polus A, Goralska J, Zdzienicka A, et al
    Effect of insulin resistance on whole blood mRNA and microRNA expression affecting bone turnover.
    Eur J Endocrinol. 2019;181:525-537.
    PubMed     Abstract available


    August 2019
  43. CORICA D, Zusi C, Olivieri F, Marigliano M, et al
    Vitamin D affects insulin sensitivity and beta-cell function in obese non-diabetic youths.
    Eur J Endocrinol. 2019 Aug 1. pii: EJE-19-0369.R1. doi: 10.1530/EJE-19-0369.
    PubMed     Abstract available


    April 2019
  44. KUMARENDRAN B, Sumilo D, O'Reilly MW, Toulis KA, et al
    Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study.
    Eur J Endocrinol. 2019;180:265-272.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obesity is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: